Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study
Media Advisory Monday, March 6, 2023 What A clinical trial tests a freeze-dried, temperature-secure experimental tuberculosis (TB) vaccine in healthier older people found that it was safe and sound and stimulated both equally antibodies and responses from the cellular arm…